Cite Filings / LXEO / 0001104659-25-114635

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Lexeo Therapeutics, Inc. Filed 2025-11-20 Acc 0001104659-25-114635

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-01-21 SCHEDULE 13G Statement of Beneficial Ownership
2025-11-20 4 Chief Development Officer sold 386 shares at $9.27 ($3,578)
2025-11-20 4 Chief Executive Officer sold 1,127 shares at $9.27 ($10,447)
2025-11-20 4 Chief Legal Officer sold 549 shares at $9.27 ($5,089)
2025-11-20 4 Chief Medical Officer sold 615 shares at $9.27 ($5,701)
2025-11-20 SCHEDULE 13G Statement of Beneficial Ownership
2025-10-27 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…